https://www.clinicaltrialsarena.com/news/technodermaiia-trial-atopic/
Technoderma begins dosing in atopic dermatitis therapy trial
Apr 30, 2024 - Technoderma Medicines has begun dosing patients in its Phase IIa clinical trial of topical TDM-180935 ointment for atopic dermatitis (AD).
atopic dermatitisbeginsdosingtherapytrial
https://www.biopharmaapac.com/news/75/5768/technoderma-medicines-announces-positive-phase-2a-results-for-tdm-180935-in-atopic-dermatitis.html
Technoderma Medicines Announces Positive Phase 2a Results for TDM-180935 in Atopic Dermatitis
clinical development in dermatologic treatments